Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

King to restate financial results

Executive Summary

King's restatement of its financial results for the past two-and-a-half years will shift certain product return expenses from 2004 to reporting periods in 2003 and 2002, thereby boosting revenue and income in the current year. Restatement was necessary due to "methodological flaws" concerning the timing of expense recognition for product returns, King said. The action could threaten Mylan's pending acquisition of King; Mylan has the option of withdrawing from the deal if King makes a restatement (1"The Pink Sheet" Nov. 1, 2004, p. 21)...

King's restatement of its financial results for the past two-and-a-half years will shift certain product return expenses from 2004 to reporting periods in 2003 and 2002, thereby boosting revenue and income in the current year. Restatement was necessary due to "methodological flaws" concerning the timing of expense recognition for product returns, King said. The action could threaten Mylan's pending acquisition of King; Mylan has the option of withdrawing from the deal if King makes a restatement (1 , p. 21)....

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045098

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel